Evolution of the Average Target: Geron Corporation

Evolution of the Average Target - Geron Corporation

Evolution of the Target Price: Geron Corporation

Evolution of the Target Price - Geron Corporation

Changes in Analyst Recommendations: Geron Corporation

b9615fa1635f60ab8fc312acf8459.vDsjIYgao-PPH53Cv4nql9U1teDs_u-uVWVNl6eUtd8.231Bb_BOydTiUfWM9cyb3OJR8picxt3fBAcq_pTW9IvUd3dIu333j_5M8g~153c6164dff8d47a9bf2cd7e4661f932
06/11 Wedbush Cuts Price Target on Geron to $5 From $6, Keeps Outperform Rating MT
08/25/08 Scotiabank Downgrades Geron to Sector Perform From Sector Outperform, Adjusts Price Target to $1.50 From $4 MT
27/25/27 B. Riley Downgrades Geron to Neutral From Buy, Cuts Price Target to $2 From $3.50 MT
27/25/27 Wedbush Lowers Geron's Price Target to $7 From $8, Outperform Rating Maintained MT
26/25/26 HC Wainwright Downgrades Geron to Neutral From Buy MT
18/25/18 B. Riley Adjusts Geron Price Target to $3.50 From $5.50, Maintains Buy Rating MT
16/24/16 Scotiabank Initiates Geron at Sector Outperform With $6 Price Target MT
09/24/09 Leerink Partners Initiates Coverage on Geron With Outperform Rating, $7 Price Target MT
09/24/09 B. Riley Adjusts Price Target on Geron to $5.50 From $5, Maintains Buy Rating MT
10/24/10 Barclays Initiates Geron at Overweight Rating With $9 Price Target MT
10/24/10 Stifel Nicolaus Adjusts Geron Price Target to $7 From $6, Maintains Buy Rating MT
08/24/08 Wedbush Raises Geron's Price Target to $8 From $7, Outperform Rating Maintained MT
07/24/07 Needham Adjusts Geron Price Target to $6 From $5, Maintains Buy Rating MT
03/24/03 Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating MT
30/24/30 Baird Downgrades Geron to Neutral From Outperform, Price Target at $4.50 MT
29/24/29 TD Cowen Initiates Geron With Buy Rating, $10 Price Target MT
15/24/15 Needham Adjusts Geron's Price Target to $5 From $4, Maintains Buy Rating MT
15/24/15 Goldman Sachs Adjusts Price Target on Geron to $5 From $4, Keeps Buy Rating MT
12/23/12 Goldman Sachs Upgrades Geron to Buy From Neutral, Price Target is $4 MT
28/23/28 Goldman Sachs Initiates Geron at Neutral With $3 Price Target MT
09/23/09 Needham Adjusts Price Target on Geron to $4 From $3, Maintains Buy Rating MT
09/23/09 B. Riley Lifts Geron's PT to $5 From $4, Keeps Buy Rating After Positive Topline Results From Phase III Trial of Imetelstat MT
04/23/04 Wedbush Lifts Geron's Price Target to $6 From $5, Keeps Outperform Rating MT
28/22/28 Wedbush Starts Geron at Outperform With $5 Price Target MT
12/22/12 Needham & Co Adjusts Geron Price Target to $3 From $2, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+263.25%
+32.97%
+14.74%
+38.45%
+12.07%
+18.26%
+44.87%
+38.06%
+24.78%
+8.87%
Average +49.63%
Weighted average by Cap. +27.23%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.170USD
Average target price
4.250USD
Spread / Average Target
+263.25%
High Price Target
6.000USD
Spread / Highest target
+412.82%
Low Price Target
3.000USD
Spread / Lowest Target
+156.41%

Analyst Consensus Detail

Analyst consensus - Geron Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Geron Corporation
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Geron Corporation
  1. Stock Market
  2. Stocks
  3. GERN Stock
  4. Consensus Geron Corporation